期刊文献+

糖尿病肾病血液透析难点分析与对策 被引量:7

Strategies and analysis of difficulties on hemodialysis for diabetic nephropathy
下载PDF
导出
摘要 目的应用血液透析方法治疗糖尿病肾病患者肾衰竭,探讨糖尿病肾病患者血液透析的难点及应对策略,旨在加强和提高该类患者的血液透析治疗水平。方法采取患者对照研究,以我院2001年1月~2008年1月间行血液透析的糖尿病肾病患者53例为治疗组,非糖尿病肾病患者50例为对照组,观察两组进行透析时的肌酐、尿素氮和血糖水平及透析并发症的发生情况等。结果两组透析前血糖水平差异有统计学意义,但肌酐、尿素氮情况差异无统计学意义;并发症的发生情况治疗组明显高于对照组,差异有统计学意义;治疗组组内比较,治疗后死亡患者介入透析时肌酐尿素氮水平明显高于生存患者;治疗组血管通路建立难点较大。结论血液透析在糖尿病肾病中应用确切有效,但并发症多、血管通路建立有一定难度,应根据患者情况,采取个体化透析策略和血管通路建立。 Objective Hemodialysis was performed on the patients with chronic renal failure caused by diabetic nephropathy. We discussed the difficulties and strategies on hemodialysis for diabetic nephropathy, in order to improve the quality of the treatment of hemodialysis.Methods By using case-control study, we retrospectively analysised the patients with hemodialysis during 2001,1 - 2008, 1,which was divided into diabetic nephropathy group(53 cases)and non-diabetic nephropathy group(50 cases). The serum creafinine, serum urea nitrogen, blood glucose and complications of hemodailysis were observed. Results There were no significant differences of the levels of serum creatinine and urea nitrogen between the two groups,but the incidence d complications was obviously higher in diabetic nephropathy group than in non-diabetic nephropathy group( P 〈 0.05).In diabetic nephropathy group,the levels of serum creatinine and urea nitrogen after hemodialysis were significantly higher in died patients than survivors. Besides, the establishment of hemodialysis vascular access was more difficult in diabetic nephropathy group. Conclusion Hemodailysis was effective on the treatment of end stage renal failure caused by diabetic nephropaty with more complications and difficulties on the establishment of hemodialysis vascular access than non-diabetic nephropaty,so we should take hemodialysis and establish vascular access by individualization.
出处 《四川医学》 CAS 2009年第4期548-550,共3页 Sichuan Medical Journal
关键词 糖尿病肾病 血液透析 ESDN hemodialysis
  • 相关文献

参考文献6

  • 1叶任高.内科学[M] 第5版[M].北京:人民卫生出版社,2000.370-371.
  • 2Kimmel PL, Varela MP, Peterson PA, et al. Interdialytic weight gain and survival in hemodialysis patients:effects of duration of ESRD and diabetes mellitus[ J]. Kidney Int,2000,57(3) : 1141 - 1151
  • 3Morioka T, Emoto M, Tabam T,et al. Glycemic control is a predictor of survival for diabetic pstients on hemodialysis[J]. Diabetes Care, 2001,24(5):909-913
  • 4Kimmel PL, Vareh MP,Peterson RA, et al. htetdialyllc weight gain and survival in hemodialysis patients: effects d duration d ESRD and diabet semilitus[J].Kidneylnt,2000,57(3):11
  • 5李明喜,李学旺,李莉,冯月辉,赵琳.血液透析治疗中的血压降低与高血压[J].中华肾脏病杂志,2001,17(6):417-418. 被引量:63
  • 6Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in europe and the united states: results from the DOPPS[J].Kidney Int,2002,61(1):305-316

二级参考文献1

共引文献213

同被引文献85

引证文献7

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部